Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin
To assess the efficacy and safety of an experimental course of antiviral therapy with recombinant IL-1β in combination with recombinant interferon-α2b and ribavirin in patients with chronic hepatitis C infected with genotype 1 hepatitis C virus in lacking the virologic response to previous dual ther...
Saved in:
| Main Authors: | Yu. V. Lobzin, K. V. Zhdanov, A. S. Simbirtsev, A. A. Yakovlev, S. N. Kizhlo, V. H. Fazilov, S. N. Zharov, M. F. Lebedev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2014-09-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01) -
Sequence variation of the HVR1 region of Hepatitis C virus in response to interferon-α and ribavirin treatment
by: Ahmed Ali Al-Qahtani, et al.
Published: (2011-05-01) -
EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMBINANT INTERFERON AND BETAMETHASONE IN THE TREATMENT OF HAY FEVER DURING PERIODS OF EXACERBATION
by: A. A. Ryabtseva, et al.
Published: (2016-09-01) -
ACTIVATION OF SYNTHESIS OF ENDOGENOUS INTERFERON (REVIEW)
by: V. V. Poloskov, et al.
Published: (2019-01-01) -
Certification of a pharmacopoeial reference standard for potency testing of recombinant interferon α-2b
by: L. A. Gaiderova, et al.
Published: (2024-03-01)